A UK clinic reports that non-prescribed ketamine use can lead to bladder problems starting as early as age 13, according to a new clinical letter.
A UK clinic dedicated to treating bladder problems associated with ketamine misuse has reported seeing teenagers as young as 13. The finding comes from a clinical letter published in the Archives of Disease in Childhood.
The clinic's data suggest that non-prescribed ketamine use may start at age 13, leading to bladder damage at an early age. The letter highlights the urological risks of recreational ketamine use among adolescents.
The Trump administration's preliminary Medicare lab payment cuts could undermine access to critical diagnostic testing, according to the American Clinical Laboratory Association.
A roundup of endocrinology news includes a small trial of stem cells for osteoporosis, new weight-loss data, and a link between bone density and cognition.
A viral sports event controversy reveals how common fecal incontinence is, yet how rarely it is discussed openly.
New FDA rule and $88 million in NIH funding aim to shift drug safety testing toward human-based methods.